衞寧健康(300253.SZ):衞寧科技獲大健康基金單方面增資2億元
格隆匯11月15日丨衞寧健康(300253.SZ)公佈,上海金仕達衞寧軟件科技有限公司(“衞寧科技”)系公司的參股公司,目前註冊資本為5200萬元,股權結構為:衞寧健康持股50%、中國人壽持股23.077%、趙蒙海持股26.923%。
2019年11月15日,衞寧健康、中國人壽、趙蒙海、國壽成達(上海)健康產業股權投資中心(有限合夥)(“大健康基金”)及衞寧科技共同簽署了《增資協議》,各方一致同意大健康基金擬以人民幣2億元對衞寧科技單方面增資,其中866.67萬元計入衞寧科技的註冊資本,剩餘約1.91億元計入衞寧科技的資本公積。衞寧健康、中國人壽、趙蒙海均放棄此次增資優先認繳權。
此次交易完成後,衞寧科技的註冊資本將由5200萬元增加至6066.67萬元。衞寧健康持有衞寧科技的股權由50%變更為42.86%,衞寧科技仍為無控股股東、無實際控制人的企業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.